JP2023500573A5 - - Google Patents
Info
- Publication number
- JP2023500573A5 JP2023500573A5 JP2022520658A JP2022520658A JP2023500573A5 JP 2023500573 A5 JP2023500573 A5 JP 2023500573A5 JP 2022520658 A JP2022520658 A JP 2022520658A JP 2022520658 A JP2022520658 A JP 2022520658A JP 2023500573 A5 JP2023500573 A5 JP 2023500573A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- pharmaceutical composition
- composition according
- amino acid
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962925111P | 2019-10-23 | 2019-10-23 | |
| US62/925,111 | 2019-10-23 | ||
| PCT/US2020/056901 WO2021081232A1 (en) | 2019-10-23 | 2020-10-22 | Modified cytotoxic t cells and methods of use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023500573A JP2023500573A (ja) | 2023-01-10 |
| JP2023500573A5 true JP2023500573A5 (https=) | 2023-10-25 |
Family
ID=75620832
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022520658A Pending JP2023500573A (ja) | 2019-10-23 | 2020-10-22 | 改変された細胞傷害性ｔ細胞及びその使用方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US20230000914A1 (https=) |
| EP (1) | EP4048402A4 (https=) |
| JP (1) | JP2023500573A (https=) |
| CN (1) | CN114423497A (https=) |
| AU (1) | AU2020369573A1 (https=) |
| CA (1) | CA3146903A1 (https=) |
| IL (1) | IL290297A (https=) |
| WO (1) | WO2021081232A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2973548T3 (es) | 2016-12-22 | 2024-06-20 | Cue Biopharma Inc | Polipéptidos multiméricos moduladores de linfocitos T y métodos para su uso |
| EP3565829A4 (en) | 2017-01-09 | 2021-01-27 | Cue Biopharma, Inc. | T-CELL-MODULATING MULTIMERIC POLYPEPTIDES AND METHOD OF USING THEREOF |
| US20200010528A1 (en) | 2017-03-15 | 2020-01-09 | Cue Biopharma, Inc. | Methods for modulating an immune response |
| JP2020534352A (ja) | 2017-09-07 | 2020-11-26 | キュー バイオファーマ，インコーポレーテッド | コンジュゲーション部位を有するｔ細胞調節多量体ポリペプチド及びその使用方法 |
| WO2021231376A2 (en) | 2020-05-12 | 2021-11-18 | Cue Biopharma, Inc. | Multimeric t-cell modulatory polypeptides and methods of use thereof |
| WO2022056014A1 (en) | 2020-09-09 | 2022-03-17 | Cue Biopharma, Inc. | Mhc class ii t-cell modulatory multimeric polypeptides for treating type 1 diabetes mellitus (t1d) and methods of use thereof |
| EP4514835A4 (en) * | 2022-04-28 | 2026-04-15 | Cue Biopharma Inc | MODIFIED CYTOXIC T LYMPHOCYTES AND ASSOCIATED METHODS OF USE |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH06510799A (ja) * | 1992-06-25 | 1994-12-01 | シティ・オブ・ホープ | サイトメガロウイルスのポリペプチドによる細胞溶解性ｔ−リンパ球の誘導 |
| US20170335281A1 (en) * | 2014-03-15 | 2017-11-23 | Novartis Ag | Treatment of cancer using chimeric antigen receptor |
| WO2015195531A2 (en) * | 2014-06-18 | 2015-12-23 | Albert Einstein College Of Medicine, Inc. | Syntac polypeptides and uses thereof |
| EP3988111A1 (en) * | 2016-04-01 | 2022-04-27 | Innovative Cellular Therapeutics Holdings, Ltd. | Use of chimeric antigen receptor modified cells to treat cancer |
| JP7002769B2 (ja) * | 2016-09-16 | 2022-02-04 | ベイラー カレッジ オブ メディスン | ウイルス特異的ｔ細胞の活性化および拡大のためのプラットフォーム |
| DE102016225436A1 (de) * | 2016-12-19 | 2018-06-21 | Volkswagen Aktiengesellschaft | Sensor zum Erfassen von Messwerten, Verfahren, Vorrichtung und computerlesbares Speichermedium mit Instruktionen zur Verarbeitung von Messwerten eines Sensors |
| ES2973548T3 (es) * | 2016-12-22 | 2024-06-20 | Cue Biopharma Inc | Polipéptidos multiméricos moduladores de linfocitos T y métodos para su uso |
| CN110121336A (zh) * | 2017-01-05 | 2019-08-13 | 弗莱德哈钦森癌症研究中心 | 改善疫苗功效的系统和方法 |
| EP3755711A4 (en) * | 2018-02-20 | 2021-11-24 | Technion Research & Development Foundation Limited | IMMUNOTHERAPEUTIC COMPOSITION FOR THE TREATMENT OF CANCER |
| KR20220015382A (ko) * | 2019-05-29 | 2022-02-08 | 큐 바이오파마, 인크. | 다량체 t-세포 조절 폴리펩타이드 및 이의 사용 방법 |
-
2020
- 2020-10-22 WO PCT/US2020/056901 patent/WO2021081232A1/en not_active Ceased
- 2020-10-22 AU AU2020369573A patent/AU2020369573A1/en active Pending
- 2020-10-22 CN CN202080063294.6A patent/CN114423497A/zh active Pending
- 2020-10-22 EP EP20880162.1A patent/EP4048402A4/en active Pending
- 2020-10-22 CA CA3146903A patent/CA3146903A1/en active Pending
- 2020-10-22 JP JP2022520658A patent/JP2023500573A/ja active Pending
-
2022
- 2022-02-02 IL IL290297A patent/IL290297A/en unknown
- 2022-02-23 US US17/678,735 patent/US20230000914A1/en active Pending
-
2025
- 2025-08-29 US US19/314,609 patent/US20260053855A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023500573A5 (https=) | ||
| JP2023500574A5 (https=) | ||
| JP2022534846A5 (https=) | ||
| JP2021525509A5 (https=) | ||
| JP2022515331A5 (https=) | ||
| CN110785435B (zh) | 与il-12和il-18的基于il-15的融合物 | |
| JP2023518049A5 (https=) | ||
| CN108884140B (zh) | 修饰的嵌合受体及相关组合物和方法 | |
| JP2022536581A5 (https=) | ||
| NZ759969A (en) | Tagged chimeric effector molecules and receptors thereof | |
| JP2017501702A5 (https=) | ||
| IL272085B2 (en) | Multimeric t-cell modulatory polypeptides and methods of use thereof | |
| RU2017121115A (ru) | Генетически модифицированные гамма дельта т-клетки | |
| JP2018525033A5 (https=) | ||
| WO2013185552A1 (zh) | 双信号独立的嵌合抗原受体及其用途 | |
| RU2017129591A (ru) | МАт-НАПРАВЛЯЕМЫЕ ХИМЕРНЫЕ АНТИГЕННЫЕ РЕЦЕПТОРНЫЕ СИСТЕМЫ ДЛЯ СОРТИРОВКИ/ИСТОЩЕНИЯ СКОНСТРУИРОВАННЫХ ИММУННЫХ КЛЕТОК | |
| US20260053855A1 (en) | Modified Cytotoxic T Cells and Methods of Use Thereof | |
| JP2018525006A5 (https=) | ||
| JP2019527041A5 (https=) | ||
| JP2021534740A5 (https=) | ||
| JP2019535262A5 (https=) | ||
| JP2021514631A5 (https=) | ||
| JP2022515330A5 (https=) | ||
| WO2016184592A1 (en) | T cell receptor with specificity for myeloperoxidase peptide and uses thereof | |
| JP2024510900A5 (https=) |